News

The Israeli Ministry of Health will finance the entire project, including the development, planning and production of the snakebite antiserum and the establishment of an antiserum manufacturing facility.

Labopharm’s marketing partner for South Korea, WhanIn Pharmaceutical launched the product under the brand name TramaConti CR and its marketing partner for Australia, iNova Pharmaceuticals, launched the product

This multi-center, randomized, double-blind, vehicle-controlled, parallel group study was designed to assess the safety and preliminary efficacy of two dose levels of topical PTH (1-34) for the treatment

The patent office issued a ‘notice of allowance’ for patent application, which covers stabilized, small interfering RNA (siRNA) molecules with defined positional modifications. The claims cover siRNA molecules

Andes, an international, double-blind trial, showed a dose-dependent, statistically significant drop in glycosylated hemoglobin (A1c) of 0.6% and 0.4% in the 150mg and 75mg arms, respectively, at six

Bristol-Myers Squibb currently owns approximately 17% of all outstanding shares of ImClone. Bristol-Myers Squibb’s all-cash offer, which is not conditioned on the receipt of financing or on the

Based upon available information, Handa believes that it is the first applicant to file an abbreviated new drug application (ANDA) for Seroquel XR containing a paragraph IV certification,

The terms of the agreement include a $50 million upfront payment, the potential for $385 million in success-based milestones and additional sales based milestones and royalties on sales.

The court ruled in SonoSite’s favor on five of the six patents that GE had asserted. The court ruled that one of GE’s patents is invalid and that